chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Mobility decreased, Peripheral swelling, Product dose omission issue, Rash, Skin warm
Clinical narrative: Chronic gout sever flareup; pain in joints; Difficulty walking; Swollen left arm; arm was still red and hot to touch; problem with lymphatics, fluid were not moving; hot to touch; Patient was not able to move left arm; Rash on left arm; Second shot postponed for 67days; This spontaneous case was reported by a consumer and describes the occurrence of MOBILITY DECREASED (Patient was not able to move left arm), RASH (Rash on left arm), PERIPHERAL SWELLING (Swollen left arm), ERYTHEMA (arm was still red and hot to touch) and GOUT (Chronic gout sever flareup) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016M20A,) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concurrent medical conditions included Gout. Concomitant products included Diltiazem                                                      Hypertension, carafate                                                       Acid reflux and Atenolol                                                       Hypertension for an unknown indication.    On 27-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Mar-2021, the patient experienced MOBILITY DECREASED (Patient was not able to move left arm), RASH (Rash on left arm) and PRODUCT DOSE OMISSION ISSUE (Second shot postponed for 67days). On 27-Mar-2021, the patient experienced PERIPHERAL SWELLING (Swollen left arm), ERYTHEMA (arm was still red and hot to touch), LYMPHATIC DISORDER (problem with lymphatics, fluid were not moving) and SKIN WARM (hot to touch). On 03-Apr-2021, the patient experienced GOUT (Chronic gout sever flareup), ARTHRALGIA (pain in joints) and GAIT DISTURBANCE (Difficulty walking). At the time of the report, MOBILITY DECREASED (Patient was not able to move left arm), RASH (Rash on left arm), PERIPHERAL SWELLING (Swollen left arm), ERYTHEMA (arm was still red and hot to touch), GOUT (Chronic gout sever flareup), ARTHRALGIA (pain in joints), GAIT DISTURBANCE (Difficulty walking), PRODUCT DOSE OMISSION ISSUE (Second shot postponed for 67days), LYMPHATIC DISORDER (problem with lymphatics, fluid were not moving) and SKIN WARM (hot to touch) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Chills, Diarrhoea, Illness, Pyrexia
Clinical narrative: fever; Chills; diarrhea; sick; weak; This spontaneous case was reported by an other and describes the occurrence of PYREXIA (fever), CHILLS (Chills), DIARRHOEA (diarrhea), ILLNESS (sick) and ASTHENIA (weak) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031A21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 22-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Mar-2021, the patient experienced PYREXIA (fever), CHILLS (Chills), DIARRHOEA (diarrhea), ILLNESS (sick) and ASTHENIA (weak). At the time of the report, PYREXIA (fever), CHILLS (Chills), DIARRHOEA (diarrhea), ILLNESS (sick) and ASTHENIA (weak) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       No concomitant medications were provided. No treatment details were provided.   This case was linked to MOD-2021-026683 (Patient Link).
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain, Herpes zoster, Hypoaesthesia, Myalgia, Paraesthesia
Clinical narrative: Body aches; Fever; rashes on the whole of her right side, from her under arm to her wasit down to her hips; it is splotchy; Shingles; Prickling/Tingling; Abdominal cramping; numbness; Pruritus; This spontaneous case was reported by a consumer and describes the occurrence of HERPES ZOSTER (Shingles), PARAESTHESIA (Prickling/Tingling), ABDOMINAL PAIN (Abdominal cramping), HYPOAESTHESIA (numbness) and PRURITUS (Pruritus) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included CYANOCOBALAMIN (B12 [CYANOCOBALAMIN]) from 01-Mar-2018 to an unknown date for Vitamin B12 deficiency.    On 17-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-May-2021, the patient experienced HERPES ZOSTER (Shingles), PARAESTHESIA (Prickling/Tingling), ABDOMINAL PAIN (Abdominal cramping), HYPOAESTHESIA (numbness) and PRURITUS (Pruritus). On an unknown date, the patient experienced MYALGIA (Body aches) and PYREXIA (Fever). The patient was treated with PREGABALIN for Pain, at an unspecified dose and frequency and VALACYCLOVIR [VALACICLOVIR] from 05-May-2021 to 12-May-2021 for Shingles, at a dose of 1 gram three times a day. At the time of the report, HERPES ZOSTER (Shingles), PARAESTHESIA (Prickling/Tingling), ABDOMINAL PAIN (Abdominal cramping), HYPOAESTHESIA (numbness) and PRURITUS (Pruritus) had not resolved and MYALGIA (Body aches) and PYREXIA (Fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Patient feels like a bad sunburn at the site of rash.   Most recent FOLLOW-UP information incorporated above includes: On 05-Jun-2021: Follow-up information received and concomitant product, treatment information and event shingles were added. On 25-Jun-2021: Follow-up information received and new Events and Treatment medication were added.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Pyrexia, Rash, Rash macular
Clinical narrative: Body aches; Fever; rashes on the whole of her right side, from her under arm to her wasit down to her hips; it is splotchy; Shingles; Prickling/Tingling; Abdominal cramping; numbness; Pruritus; This spontaneous case was reported by a consumer and describes the occurrence of HERPES ZOSTER (Shingles), PARAESTHESIA (Prickling/Tingling), ABDOMINAL PAIN (Abdominal cramping), HYPOAESTHESIA (numbness) and PRURITUS (Pruritus) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included CYANOCOBALAMIN (B12 [CYANOCOBALAMIN]) from 01-Mar-2018 to an unknown date for Vitamin B12 deficiency.    On 17-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-May-2021, the patient experienced HERPES ZOSTER (Shingles), PARAESTHESIA (Prickling/Tingling), ABDOMINAL PAIN (Abdominal cramping), HYPOAESTHESIA (numbness) and PRURITUS (Pruritus). On an unknown date, the patient experienced MYALGIA (Body aches) and PYREXIA (Fever). The patient was treated with PREGABALIN for Pain, at an unspecified dose and frequency and VALACYCLOVIR [VALACICLOVIR] from 05-May-2021 to 12-May-2021 for Shingles, at a dose of 1 gram three times a day. At the time of the report, HERPES ZOSTER (Shingles), PARAESTHESIA (Prickling/Tingling), ABDOMINAL PAIN (Abdominal cramping), HYPOAESTHESIA (numbness) and PRURITUS (Pruritus) had not resolved and MYALGIA (Body aches) and PYREXIA (Fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Patient feels like a bad sunburn at the site of rash.   Most recent FOLLOW-UP information incorporated above includes: On 05-Jun-2021: Follow-up information received and concomitant product, treatment information and event shingles were added. On 25-Jun-2021: Follow-up information received and new Events and Treatment medication were added.
Age: 53.0
Sex: M
Vaccine: COVID19
Symptoms: Swelling, Vaccination site pain
Clinical narrative: swelling in chest cavity; soreness in injection arm; This spontaneous case was reported by a consumer and describes the occurrence of SWELLING (swelling in chest cavity) and VACCINATION SITE PAIN (soreness in injection arm) in a 53-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 044A21A and 031A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 20-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 23-Apr-2021, the patient experienced SWELLING (swelling in chest cavity) and VACCINATION SITE PAIN (soreness in injection arm). At the time of the report, SWELLING (swelling in chest cavity) and VACCINATION SITE PAIN (soreness in injection arm) outcome was unknown.            No concomitant medications reported.  No treatment information was provided.  The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) was not applicable.
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of RASH (After 7-8 days, he started getting random rash all over his body) in a 57-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 009C21A) for COVID-19 vaccination.     Concomitant products included CARVEDILOL, SACUBITRIL VALSARTAN SODIUM HYDRATE (ENTRESTO), ATORVASTATIN, CLONAZEPAM, FLUOXETINE and BUMETANIDE for an unknown indication.    On 23-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 milliliter. On 30-Apr-2021, the patient experienced RASH (After 7-8 days, he started getting random rash all over his body). At the time of the report, RASH (After 7-8 days, he started getting random rash all over his body) had not resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Follow up on 5 May 2021: Treatment: Hydroxyzine 25mg three times a day, Benadryl, Claritin.   Most recent FOLLOW-UP information incorporated above includes: On 05-May-2021: Updated patient information(patient initials and gender). Added product information,added concomitant drugs. Added event Rash all over body outcome Not recovered. On 11-May-2021: NNI On 11-May-2021: Patient confirms visiting doctor for treatment.
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Back pain, Dyspnoea, Hypokinesia, Inappropriate schedule of product administration, Pain
Clinical narrative: unable to sit or lie down; unable to breathe at times; Back pain; back pain shooting down her legs; Received the second dose 21 days after first dose; This spontaneous case was reported by a consumer and describes the occurrence of BACK PAIN (Back pain), PAIN (back pain shooting down her legs), HYPOKINESIA (unable to sit or lie down), DYSPNOEA (unable to breathe at times) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Received the second dose 21 days after first dose) in a 41-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 06-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 27-Apr-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Received the second dose 21 days after first dose). On 28-Apr-2021, the patient experienced BACK PAIN (Back pain) and PAIN (back pain shooting down her legs). On an unknown date, the patient experienced HYPOKINESIA (unable to sit or lie down) and DYSPNOEA (unable to breathe at times). At the time of the report, BACK PAIN (Back pain), PAIN (back pain shooting down her legs), HYPOKINESIA (unable to sit or lie down) and DYSPNOEA (unable to breathe at times) outcome was unknown and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Received the second dose 21 days after first dose) had resolved. Not Provided          No concomitant medications provided. No treatment information provided.
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain upper, Headache, Speech disorder
Clinical narrative: Stomach Pain (After Second Shot); Can Hardly Talk (After Second Shot); Headache (After Second Shot); This spontaneous case was reported by an other caregiver and describes the occurrence of ABDOMINAL PAIN UPPER (Stomach Pain (After Second Shot)), SPEECH DISORDER (Can Hardly Talk (After Second Shot)) and HEADACHE (Headache (After Second Shot)) in a 44-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 038B21A and 045A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 04-May-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-May-2021, the patient experienced ABDOMINAL PAIN UPPER (Stomach Pain (After Second Shot)), SPEECH DISORDER (Can Hardly Talk (After Second Shot)) and HEADACHE (Headache (After Second Shot)). At the time of the report, ABDOMINAL PAIN UPPER (Stomach Pain (After Second Shot)), SPEECH DISORDER (Can Hardly Talk (After Second Shot)) and HEADACHE (Headache (After Second Shot)) outcome was unknown.            Concomitant medication was not provided. Treatment information was not provided.  The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) was not applicable.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Inappropriate schedule of product administration, Myalgia, Pain in extremity
Clinical narrative: Thighs are in pain, agony of pain in legs; Burning feeling in the skin; Locked up in pain; Joint pain/ joint got worse/ burning in joints; Chills; More than 36 days after the first dose without receiving second dose; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Thighs are in pain, agony of pain in legs), SKIN BURNING SENSATION (Burning feeling in the skin), CHILLS (Chills), MYALGIA (Locked up in pain) and ARTHRALGIA (Joint pain/ joint got worse/ burning in joints) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 039B21A and 047A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Knee replacement (Bilateral knee replacements (synthetic knees)). Concurrent medical conditions included Deep vein thrombosis. Concomitant products included APIXABAN (ELIQUIS) for DVT, ROSUVASTATIN CALCIUM (CRESTOR) for an unknown indication.   On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 03-Mar-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (More than 36 days after the first dose without receiving second dose). On 01-May-2021, the patient experienced CHILLS (Chills). On 02-May-2021, the patient experienced PAIN IN EXTREMITY (Thighs are in pain, agony of pain in legs), SKIN BURNING SENSATION (Burning feeling in the skin), MYALGIA (Locked up in pain) and ARTHRALGIA (Joint pain/ joint got worse/ burning in joints). The patient was treated with PARACETAMOL (TYLENOL) for Pain relief, at an unspecified dose and frequency and OXYCODONE for Pain relief, at an unspecified dose and frequency. On 01-May-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (More than 36 days after the first dose without receiving second dose) had resolved. On 02-May-2021, CHILLS (Chills) had resolved. At the time of the report, PAIN IN EXTREMITY (Thighs are in pain, agony of pain in legs), SKIN BURNING SENSATION (Burning feeling in the skin), MYALGIA (Locked up in pain) and ARTHRALGIA (Joint pain/ joint got worse/ burning in joints) outcome was unknown.            Most recent FOLLOW-UP information incorporated above includes: On 04-Jun-2021: Follow-up was received on 4-Jun-2021 and included email updates
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Skin burning sensation
Clinical narrative: Thighs are in pain, agony of pain in legs; Burning feeling in the skin; Locked up in pain; Joint pain/ joint got worse/ burning in joints; Chills; More than 36 days after the first dose without receiving second dose; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Thighs are in pain, agony of pain in legs), SKIN BURNING SENSATION (Burning feeling in the skin), CHILLS (Chills), MYALGIA (Locked up in pain) and ARTHRALGIA (Joint pain/ joint got worse/ burning in joints) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 039B21A and 047A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Knee replacement (Bilateral knee replacements (synthetic knees)). Concurrent medical conditions included Deep vein thrombosis. Concomitant products included APIXABAN (ELIQUIS) for DVT, ROSUVASTATIN CALCIUM (CRESTOR) for an unknown indication.   On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 03-Mar-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (More than 36 days after the first dose without receiving second dose). On 01-May-2021, the patient experienced CHILLS (Chills). On 02-May-2021, the patient experienced PAIN IN EXTREMITY (Thighs are in pain, agony of pain in legs), SKIN BURNING SENSATION (Burning feeling in the skin), MYALGIA (Locked up in pain) and ARTHRALGIA (Joint pain/ joint got worse/ burning in joints). The patient was treated with PARACETAMOL (TYLENOL) for Pain relief, at an unspecified dose and frequency and OXYCODONE for Pain relief, at an unspecified dose and frequency. On 01-May-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (More than 36 days after the first dose without receiving second dose) had resolved. On 02-May-2021, CHILLS (Chills) had resolved. At the time of the report, PAIN IN EXTREMITY (Thighs are in pain, agony of pain in legs), SKIN BURNING SENSATION (Burning feeling in the skin), MYALGIA (Locked up in pain) and ARTHRALGIA (Joint pain/ joint got worse/ burning in joints) outcome was unknown.            Most recent FOLLOW-UP information incorporated above includes: On 04-Jun-2021: Follow-up was received on 4-Jun-2021 and included email updates
Sex: M
Vaccine: COVID19
Symptoms: Fatigue
Clinical narrative: tiredness / fatigue; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (tiredness / fatigue) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concomitant products included DILTIAZEM for an unknown indication.    On 09-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced FATIGUE (tiredness / fatigue). Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   This case was linked to MOD-2021-106361 (Patient Link).
Age: 88.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Cough, Malaise, Pain in extremity
Clinical narrative: coughing; arm was hurting; had no energy; in bed for a week; This spontaneous case was reported by a consumer and describes the occurrence of COUGH (coughing), PAIN IN EXTREMITY (arm was hurting), ASTHENIA (had no energy) and MALAISE (in bed for a week) in an 88-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Surgery (MELANOMA SURGERY).    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced COUGH (coughing), PAIN IN EXTREMITY (arm was hurting), ASTHENIA (had no energy) and MALAISE (in bed for a week). At the time of the report, COUGH (coughing), PAIN IN EXTREMITY (arm was hurting), ASTHENIA (had no energy) and MALAISE (in bed for a week) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Sex: M
Vaccine: COVID19
Symptoms: Chills, Fatigue, Feeling cold, Insomnia, Pain in extremity
Clinical narrative: Arm soreness; Hard time sleeping; Couldn't get warm; Fatigue; Chills; Fever; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm soreness), INSOMNIA (Hard time sleeping), FEELING COLD (Couldn't get warm), FATIGUE (Fatigue) and CHILLS (Chills) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 030B21A and 026B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 03-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 03-May-2021, the patient experienced PAIN IN EXTREMITY (Arm soreness), INSOMNIA (Hard time sleeping), FEELING COLD (Couldn't get warm), FATIGUE (Fatigue), CHILLS (Chills) and PYREXIA (Fever). At the time of the report, PAIN IN EXTREMITY (Arm soreness), INSOMNIA (Hard time sleeping), FEELING COLD (Couldn't get warm), FATIGUE (Fatigue), CHILLS (Chills) and PYREXIA (Fever) had not resolved.            No concomitant medications were reported.  No treatment information was provided.   Reporter did not allow further contact
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Arm soreness; Hard time sleeping; Couldn't get warm; Fatigue; Chills; Fever; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm soreness), INSOMNIA (Hard time sleeping), FEELING COLD (Couldn't get warm), FATIGUE (Fatigue) and CHILLS (Chills) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 030B21A and 026B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 03-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 03-May-2021, the patient experienced PAIN IN EXTREMITY (Arm soreness), INSOMNIA (Hard time sleeping), FEELING COLD (Couldn't get warm), FATIGUE (Fatigue), CHILLS (Chills) and PYREXIA (Fever). At the time of the report, PAIN IN EXTREMITY (Arm soreness), INSOMNIA (Hard time sleeping), FEELING COLD (Couldn't get warm), FATIGUE (Fatigue), CHILLS (Chills) and PYREXIA (Fever) had not resolved.            No concomitant medications were reported.  No treatment information was provided.   Reporter did not allow further contact
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pain, Vaccination site warmth
Clinical narrative: hotness; injection site pain; redness; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (hotness), VACCINATION SITE PAIN (injection site pain) and VACCINATION SITE ERYTHEMA (redness) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 017821A) for COVID-19 vaccination.     Concomitant products included OXYBUTYNIN for Bladder disorder, OMEPRAZOLE for Gastrointestinal disorder, LEVOTHYROXINE for an unknown indication.    On 04-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-May-2021, the patient experienced VACCINATION SITE WARMTH (hotness), VACCINATION SITE PAIN (injection site pain) and VACCINATION SITE ERYTHEMA (redness). At the time of the report, VACCINATION SITE WARMTH (hotness), VACCINATION SITE PAIN (injection site pain) and VACCINATION SITE ERYTHEMA (redness) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment details were not provided.
Sex: M
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: missed his 2nd dose of Moderna vaccine; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (missed his 2nd dose of Moderna vaccine) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (missed his 2nd dose of Moderna vaccine). At the time of the report, PRODUCT DOSE OMISSION ISSUE (missed his 2nd dose of Moderna vaccine) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The patient stated "No" when asked about if any treatment received or is on any concomitant medications.
Age: 44.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test
Clinical narrative: Diagnose with COVID after receiving the first dose; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Diagnose with COVID after receiving the first dose) in a 44-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038B21A) for COVID-19 vaccination.     No medical history was provided by the reporter.     On 10-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Apr-2021, the patient experienced COVID-19 (Diagnose with COVID after receiving the first dose). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency and IBUPROFEN (MOTRIN [IBUPROFEN]) at an unspecified dose and frequency. At the time of the report, COVID-19 (Diagnose with COVID after receiving the first dose) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 28-Apr-2021, SARS-CoV-2 test: positive (Positive) Positive for COVID-19.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product information includes Blood Pressure Medication.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Somnolence
Clinical narrative: sleepy; very tired; This spontaneous case was reported by a consumer and describes the occurrence of SOMNOLENCE (sleepy) and FATIGUE (very tired) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Fibromyalgia.   On 25-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced SOMNOLENCE (sleepy) and FATIGUE (very tired). At the time of the report, SOMNOLENCE (sleepy) and FATIGUE (very tired) had resolved. Not Provided          On an unknown date, the patient was prescribed with steroid medication for fibromyalgia. No treatment medication were reported.
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Myalgia, Varicose vein
Clinical narrative: varicose veins in legs; Chills; body aches; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (Chills), MYALGIA (body aches) and VARICOSE VEIN (varicose veins in legs) in a 62-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 09-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On 30-Apr-2021, the patient experienced CHILLS (Chills) and MYALGIA (body aches). On 03-May-2021, the patient experienced VARICOSE VEIN (varicose veins in legs). On 01-May-2021, CHILLS (Chills) and MYALGIA (body aches) had resolved. At the time of the report, VARICOSE VEIN (varicose veins in legs) outcome was unknown. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   This case was linked to MOD-2021-106335 (Patient Link).
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Feeling abnormal, Headache, Mobility decreased, Myalgia
Clinical narrative: feeling horrible; couldn't move her left arm; whole body ached so bad; slight headache; nausea; fever; chills and stated she was "so cold" and "couldn't get warm"; slight body aches; This spontaneous case was reported by a nurse and describes the occurrence of CHILLS (chills and stated she was "so cold" and "couldn't get warm"), MYALGIA (slight body aches), FEELING ABNORMAL (feeling horrible), MOBILITY DECREASED (couldn't move her left arm) and MYALGIA (whole body ached so bad) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 040B21A and 013L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Diabetes and Drug allergy (cipro). Concomitant products included GLIPIZIDE, METFORMIN, SIMVASTATIN, LOSARTAN, VITAMIN D NOS, CALCIUM, ZINC and MAGNESIUM for an unknown indication.   On 16-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 13-Apr-2021, the patient experienced CHILLS (chills and stated she was "so cold" and "couldn't get warm") and MYALGIA (slight body aches). On 04-May-2021, the patient experienced FEELING ABNORMAL (feeling horrible), MOBILITY DECREASED (couldn't move her left arm) and MYALGIA (whole body ached so bad). 04-May-2021, the patient experienced HEADACHE (slight headache), NAUSEA (nausea) and PYREXIA (fever). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, CHILLS (chills and stated she was "so cold" and "couldn't get warm"), MYALGIA (slight body aches), FEELING ABNORMAL (feeling horrible), MOBILITY DECREASED (couldn't move her left arm), MYALGIA (whole body ached so bad), HEADACHE (slight headache), NAUSEA (nausea) and PYREXIA (fever) outcome was unknown. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Pyrexia
Clinical narrative: feeling horrible; couldn't move her left arm; whole body ached so bad; slight headache; nausea; fever; chills and stated she was "so cold" and "couldn't get warm"; slight body aches; This spontaneous case was reported by a nurse and describes the occurrence of CHILLS (chills and stated she was "so cold" and "couldn't get warm"), MYALGIA (slight body aches), FEELING ABNORMAL (feeling horrible), MOBILITY DECREASED (couldn't move her left arm) and MYALGIA (whole body ached so bad) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 040B21A and 013L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Diabetes and Drug allergy (cipro). Concomitant products included GLIPIZIDE, METFORMIN, SIMVASTATIN, LOSARTAN, VITAMIN D NOS, CALCIUM, ZINC and MAGNESIUM for an unknown indication.   On 16-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 13-Apr-2021, the patient experienced CHILLS (chills and stated she was "so cold" and "couldn't get warm") and MYALGIA (slight body aches). On 04-May-2021, the patient experienced FEELING ABNORMAL (feeling horrible), MOBILITY DECREASED (couldn't move her left arm) and MYALGIA (whole body ached so bad). 04-May-2021, the patient experienced HEADACHE (slight headache), NAUSEA (nausea) and PYREXIA (fever). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, CHILLS (chills and stated she was "so cold" and "couldn't get warm"), MYALGIA (slight body aches), FEELING ABNORMAL (feeling horrible), MOBILITY DECREASED (couldn't move her left arm), MYALGIA (whole body ached so bad), HEADACHE (slight headache), NAUSEA (nausea) and PYREXIA (fever) outcome was unknown. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Age: 30.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect dose administered
Clinical narrative: Incomplete dose administered; This spontaneous case was reported by a pharmacist and describes the occurrence of INCORRECT DOSE ADMINISTERED (Incomplete dose administered) in a 30-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Mar-2021, the patient experienced INCORRECT DOSE ADMINISTERED (Incomplete dose administered). At the time of the report, INCORRECT DOSE ADMINISTERED (Incomplete dose administered) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Sex: F
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: Missed the second dose; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (Missed the second dose) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (Missed the second dose). At the time of the report, PRODUCT DOSE OMISSION ISSUE (Missed the second dose) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment drugs were not provided concomitant drugs were not provided
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: Abdominal pain, Diarrhoea
Clinical narrative: abdominal pain; diarrhea; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL PAIN (abdominal pain) and DIARRHOEA (diarrhea) in a 63-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 0161321A) for COVID-19 vaccination.     No Medical History information was reported.    On 30-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-May-2021, the patient experienced ABDOMINAL PAIN (abdominal pain) and DIARRHOEA (diarrhea). At the time of the report, ABDOMINAL PAIN (abdominal pain) and DIARRHOEA (diarrhea) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications provided. No treatment information provided.
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Pain in right arm / t lifted up the arm and still sore for a week) in a 74-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 045B21A) for COVID-19 vaccination. No Medical History information was reported. On 26-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Apr-2021, the patient experienced PAIN IN EXTREMITY (Pain in right arm / t lifted up the arm and still sore for a week). The patient was treated with NAPROXEN SODIUM (ALEVE) at a dose of 1 dosage form. At the time of the report, PAIN IN EXTREMITY (Pain in right arm / t lifted up the arm and still sore for a week) outcome was unknown. Not Provided. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medications were reported.
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Nasopharyngitis
Clinical narrative: very light cold like something; This spontaneous case was reported by a consumer and describes the occurrence of NASOPHARYNGITIS (very light cold like something) in a 77-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-Apr-2021, the patient experienced NASOPHARYNGITIS (very light cold like something). On 11-Apr-2021, NASOPHARYNGITIS (very light cold like something) had resolved. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, COVID-19: Negative.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No Relevant concomitant medications was reported.  Treatment information was not provided.    This case was linked to MOD-2021-106412 (Patient Link).
Age: 44.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Nasopharyngitis
Clinical narrative: chills; super cold; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (chills) and NASOPHARYNGITIS (super cold) in a 44-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 047B21A) for COVID-19 vaccination.     Concomitant products included CABERGOLINE for an unknown indication.    On 29-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-May-2021, the patient experienced CHILLS (chills) and NASOPHARYNGITIS (super cold). At the time of the report, CHILLS (chills) and NASOPHARYNGITIS (super cold) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Unknown concomitant medication for taken for blood pressure.  No treatment medications were reported.
Sex: M
Vaccine: COVID19
Symptoms: Herpes zoster, Product dose omission issue
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of HERPES ZOSTER (Shingles) and PRODUCT DOSE OMISSION ISSUE (did nto receive 2nd dose even after 3 months from the 1st dose) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Feb-2021, the patient experienced HERPES ZOSTER (Shingles). On 05-Mar-2021, the patient experienced PRODUCT DOSE OMISSION ISSUE (did nto receive 2nd dose even after 3 months from the 1st dose). On 05-Mar-2021, PRODUCT DOSE OMISSION ISSUE (did nto receive 2nd dose even after 3 months from the 1st dose) had resolved. At the time of the report, HERPES ZOSTER (Shingles) outcome was unknown. Not Provided. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medications were reported. No treatment medications were reported. Reporter did not allow further contact.
Age: 23.0
Sex: F
Vaccine: COVID19
Symptoms: Insomnia, Pruritus
Clinical narrative: Patient couldn't sleep; Body itching, Itching in arm pits, itching on torso, itching on hips; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PRURITUS (Body itching, Itching in arm pits, itching on torso, itching on hips) and INSOMNIA (Patient couldn't sleep) in a 23-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 043B21A) for COVID-19 vaccination.     Concurrent medical conditions included Allergy to antibiotic (Minocycline allergy).    On 18-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Apr-2021, the patient experienced PRURITUS (Body itching, Itching in arm pits, itching on torso, itching on hips). On 04-May-2021, the patient experienced INSOMNIA (Patient couldn't sleep). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Itching, at an unspecified dose and frequency. At the time of the report, PRURITUS (Body itching, Itching in arm pits, itching on torso, itching on hips) and INSOMNIA (Patient couldn't sleep) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provider by the reporter.    Most recent FOLLOW-UP information incorporated above includes: On 07-May-2021: Addition information received on 07 May 2021 had specification of event, areas where patient experienced itching.
Age: 19.0
Sex: M
Vaccine: COVID19
Symptoms: Influenza like illness, Oropharyngeal pain, Pain in extremity
Clinical narrative: Flu-like symptoms; Sore throat; Arm pain that lasted 24 hours; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm pain that lasted 24 hours), INFLUENZA LIKE ILLNESS (Flu-like symptoms) and OROPHARYNGEAL PAIN (Sore throat) in a 19-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031B21A. Expiration date:) for COVID-19 vaccination.     Concurrent medical conditions included Chronic tonsillitis.    On 08-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Apr-2021, the patient experienced PAIN IN EXTREMITY (Arm pain that lasted 24 hours). On 03-May-2021, the patient experienced INFLUENZA LIKE ILLNESS (Flu-like symptoms) and OROPHARYNGEAL PAIN (Sore throat). On 10-Apr-2021, PAIN IN EXTREMITY (Arm pain that lasted 24 hours) had resolved. At the time of the report, INFLUENZA LIKE ILLNESS (Flu-like symptoms) and OROPHARYNGEAL PAIN (Sore throat) was resolving. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment information was provided i.e.,   Vick Syrup Amoxicillin 500mg PO TID
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Rash, Vaccination site rash, Vaccination site warmth
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE RASH (within an hour of coming home from getting vaccination, she had a rash on her left arm), RASH (starting to spread down arm) and VACCINATION SITE WARMTH (rash is warm to the touch) in a 35-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007C21A) for COVID-19 vaccination. No Medical History information was reported. On 24-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Apr-2021, the patient experienced VACCINATION SITE RASH (within an hour of coming home from getting vaccination, she had a rash on her left arm). On 05-May-2021, the patient experienced RASH (starting to spread down arm) and VACCINATION SITE WARMTH (rash is warm to the touch). At the time of the report, VACCINATION SITE RASH (within an hour of coming home from getting vaccination, she had a rash on her left arm), RASH (starting to spread down arm) and VACCINATION SITE WARMTH (rash is warm to the touch) outcome was unknown. Not Provided. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Nausea, Vomiting
Clinical narrative: Nausea; Vomiting; Chills; This spontaneous case was reported by a consumer and describes the occurrence of NAUSEA (Nausea), VOMITING (Vomiting) and CHILLS (Chills) in a 39-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027C21A) for COVID-19 vaccination.     Concurrent medical conditions included Diabetes.    On 04-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-May-2021, the patient experienced NAUSEA (Nausea), VOMITING (Vomiting) and CHILLS (Chills). At the time of the report, NAUSEA (Nausea), VOMITING (Vomiting) and CHILLS (Chills) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications information was reported. No treatment medications were provided.  For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Myalgia, Pyrexia
Clinical narrative: chills; felt achy; fever of 101.7; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 05-May-2021 and was forwarded to Moderna on 05-May-2021.    This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (chills), MYALGIA (felt achy) and PYREXIA (fever of 101.7) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 043821A) for COVID-19 vaccination.     No Medical History information was reported.    On 04-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-May-2021, the patient experienced CHILLS (chills), MYALGIA (felt achy) and PYREXIA (fever of 101.7). At the time of the report, CHILLS (chills), MYALGIA (felt achy) and PYREXIA (fever of 101.7) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.